Harvard Intensive Review of Nephrology 2026

Description

+ Include:  videos + file sub vtt +  pdf, size:  GB

+ Target Audience: nephrologists, primary care physicians

+ Sample video: contact me for sample video

+ Information:

The Comprehensive Clinical Update and Board Review

Intensive Review of Nephrology is an online course, using live streaming, electronic Q&A, and other remote learning technologies. 

With over 70 interactive lectures, case discussions, board preparation sessions, and supplementary lectures, this program provides a comprehensive review of state-of-the-art nephrology practices. It offers accelerated learning for:

>> Clinicians seeking a practical and comprehensive review that ensures they are up to date across all major areas of nephrology: 

• The latest options for diagnosis: what to choose, when, and why
• Current evidence-based treatment and care management strategies to optimize patient outcomes
• Improved approaches to common and complex clinical challenges
• Navigating clinical controversies
• How to avoid medical mistakes

>> Physicians preparing to certify or recertify who seek a thorough, proven preparatory course in advance of their taking the Nephrology ABIM board examination:

• Daily board review questions and sessions
• Sessions to guide efficient preparation and study
• Comprehensive syllabus and home study guide

Comprehensive Education
This course spans all areas of nephrology. Sessions are led by experts in their respective fields. Coverage includes:

• Electrolytes and Acid-Base
• Glomerulonephritis
• Acute Kidney Injury
• Chronic Kidney Disease
• Genetic Kidney Disease
• Vascular Disease
• Hypertension
• End-Stage Renal Disease
• Transplantation
• Onconephrology: Cancer and the Kidney
• Pregnancy and Renal Disease
• Point-of-Care Renal Ultrasound

2026 Program Highlights

• Genetic testing for improved diagnosis, prognosis, and selection of therapy
• Introduction to point-of-care ultrasound: fundamentals for optimal image acquisition and accurate interpretation
• Physical exam of the dialysis access
• High-dose hemodiafiltration versus high-flux hemodialysis in the management of ESKD
• Further expansion of the roles of SGLT2 inhibitors, GLP-1 agonists, and finerenone in diabetic and non-diabetic kidney disease
• Novel immunosuppressive agents for glomerulonephritis, including the evolving role of Chimeric Antigen Receptor T-cell therapy (CAR-T)
• An introduction to xenotransplantation
• The role of renal-dedicated palliative care (“KidneyPal”) in Nephrology and the principles of conservative kidney management
• AI in Nephrology

Who Should Participate

+ Topics:

Day 1: Monday, August 10, 2026

• 8:45-8:50 am: Welcome Remarks/Announcements – Course Directors

• 8:50-9:35 am: Renal Physiology for the Boards – Dr. Melanie Hoenig

• 9:35-10:05 am: Basic Concepts of Immunology in Autoimmune Kidney Disease – Dr. Ramon Bonegio

• 10:05-10:10 am: Faculty Q&A – Drs. Melanie Hoenig and Ramon Bonegio

• 10:10-10:20 am: Break

• 10:20-11:05 am: Renal Pathology in 2026: Part 1 – Dr. Helmut Rennke

• 11:05-11:50 am: Renal Pathology in 2026: Part 2 – Dr. Astrid Weins

• 11:50 am-12:20 pm: Current Approaches to Urine Sediment Analysis – Dr. Martina McGrath

• 12:20-12:25 pm: Faculty Q&A – Drs. Astrid Weins, Martina McGrath, and Helmut Rennke

• 12:25-1:55 pm: Break

• 1:55-2:40 pm: IgA Nephropathy – Dr. Gerald Appel

• 2:40-3:10 pm: Metabolic Management of Kidney Stones – Dr. Gary Curhan

• 3:10-3:55 pm: AI in Nephrology: Clinical Applications – Dr. Navdeep Tangri

• 3:55-4:00 pm: Faculty Q&A – Drs. Gerald Appel, Gary Curhan, and Navdeep Tangri

• 4:00-4:15 pm: Break

• 4:15-5:00 pm: Update on Lupus Nephritis – Dr. Gerald Appel

• 5:00-5:30 pm: Membranous Nephropathy – Dr. Laurence Beck

• 5:30-6:15 pm: Anemia Management: Update and Best Practices – Dr. Brona Moloney

• 6:15-6:25 pm: Faculty Q&A – Drs. Gerald Appel and Laurence Beck

• 6:25 pm: Adjourn Day 1 Live Program

Self-Paced Study (Pre-recorded sessions):

• Glomerulonephritis: Questions & Answers Session – Dr. Gerald Appel

• Must-Know Clinical Images in Nephrology – Dr. Annie Liu

• Must-Know Board Zebras – Dr. Emily Robinson

• Nephrology Board Review Practice 1 – Dr. Finnian Mc Causland

• Nephrology Board Review Practice 2 – Dr. Gearoid McMahon

Day 2: Tuesday, August 11, 2026

• 8:45-8:50 am: Day 2 Announcements – Course Directors

• 8:50-9:35 am: Acid-Base Disorders I: Anion Gap Metabolic Acidosis – Dr. Alan Yu

• 9:35-10:35 am: Acid-Base Disorders II: Non-Gap Acidosis and Metabolic Alkalosis – Dr. Alan Yu

• 10:35-10:45 am: Break

• 10:45-11:30 am: Hyponatremia and Hypernatremia – Dr. David Mount

• 11:30 am-12:20 pm: Hypokalemia and Hyperkalemia – Dr. David Mount

• 12:20-1:50 pm: Break

• 1:50-2:35 pm: Important New Trials in GN – Dr. David Mount

• 2:35-3:20 pm: Genetics and Kidney Disease – Dr. Friedhelm Hildebrandt

• 3:20-4:05 pm: Update on Polycystic Kidney Disease – Dr. Fouad Chebib

• 4:05-4:10 pm: Faculty Q&A – Drs. David Mount, Friedhelm Hildebrandt, and Fouad Chebib

• 4:10-4:20 pm: Break

• 4:20-5:05 pm: Pediatric Nephrology – Dr. Alexis Gomez

• 5:05-5:50 pm: Genetics: How to Integrate into Practice – Dr. Ana Onuchic-Whitford

• 5:50-6:20 pm: Rapidly Progressive Glomerulonephritis – Dr. John Niles

• 6:20-6:35 pm: Faculty Q&A – Drs. Alexis Gomez, Ana Onuchic-Whitford, and John Niles

• 6:35 pm: Adjourn Day 2 Live Program

Self-Paced Study (Pre-recorded sessions):

• Electrolyte and Acid Base Disorders: Questions & Answers Session – Part 1 – Dr. Alan Yu

• Electrolyte and Acid Base Disorders: Questions & Answers Session – Part 2 – Dr. Alan Yu

• Chronic Kidney Disease in the Community: Meeting Them Where They Are – Dr. Li-Li Hsiao

• COVID-19 Vaccine in Immunocompromised Patients – Dr. Ann Woolley

• Update on Renovascular Disease – Dr. Joseph Garasic

Day 3: Wednesday, August 12, 2026

• 8:45-8:50 am: Day 3 Announcements – Course Directors

• 8:50-9:35 am: Why Do We Reject a Transplant? – Dr. Jamil Azzi

• 9:35-10:20 am: Transplant Immunosuppression for the Boards – Dr. Kaitlyn Lei

• 10:20-10:25 am: Faculty Q&A – Drs. Jamil Azzi and Kaitlyn Lei

• 10:25-10:35 am: Break

• 10:35-11:20 am: Immunological Assessment Pre- and Post-Transplant – Drs. Melissa Yeung and Indira Guleria

• 11:20 am-12:05 pm: Early Post-Transplant Management – Dr. Anil Chandraker

• 12:05-12:10 pm: Faculty Q&A – Drs. Melissa Yeung and Indira Guleria

• 12:10-1:40 pm: Break

• 1:40-2:10 pm: Donor Evaluation – Dr. Martina McGrath

• 2:10-2:40 pm: Late Loss of the Kidney Transplant – Dr. Rania El Fekih

• 2:40-3:10 pm: Infections in Transplant Recipients – Dr. Barbra Blair

• 3:10-3:40 pm: Monitoring Kidney Transplant Patients: Beyond Creatinine – Dr. Jamil Azzi

• 3:40-4:10 pm: Pre-Transplant Evaluation of Recipients – Dr. Rania El Fekih

• 4:10-4:15 pm: Faculty Q&A – Drs. Martina McGrath, Jamil Azzi, Rania El Fekih, and Barbra Blair

• 4:15-4:25 pm: Break

• 4:25-4:55 pm: Thrombotic Microangiopathies – Dr. Jean Francis

• 4:55-5:25 pm: Late Post-Transplant Medical Complications – Dr. Leonardo Riella

• 5:25-5:55 pm: KEYNOTE: Xenotransplantation – Dr. Leonardo Riella

• 5:55-6:25 pm: Geriatric Nephrology – Dr. Ernest Mandel

• 6:25-6:35 pm: Faculty Q&A – Drs. Jean Francis, Ernest Mandel, and Leonardo Riella

• 6:35 pm: Adjourn Day 3 Live Program

Self-Paced Study (Pre-recorded sessions):

• Pre-Transplant Surgical Evaluation of Recipients – Dr. Sayeed Malek

• Immunologic Basis of Kidney Disease – Dr. Vivek Kasinath

• Use of Checkpoint Inhibitors in Kidney Transplant Recipients – Dr. Naoka Murakami

• Transplant Cases: Board Review – Drs. Melissa Yeung and Edgar Milford

• Transplant Board Review – Dr. Anil Chandraker

• Poisonings and Intoxications: What a Nephrologist Needs to Know – Dr. Charlotte Goldfine

Day 4: Thursday, August 13, 2026

• 8:45-8:50 am: Day 4 Announcements – Course Directors

• 8:50-9:35 am: Cardiorenal Syndrome – Dr. Finnian Mc Causland

• 9:35-10:20 am: Management of Hypertension in CKD-Intensive or Standard Regimens – Dr. Richard Glassock

• 10:20-10:25 am: Faculty Q&A – Drs. Richard Glassock and Finnian Mc Causland

• 10:25-10:35 pm (am): Break (Lưu ý: Thời gian này có thể là am thay vì pm)

• 10:35-11:20 am: Primary Aldosteronism – Dr. Anand Vaidya

• 11:20-11:50 am: Therapy of FSGS Lesions in 2026 – Dr. Richard Glassock

• 11:50 am-12:20 pm: Liver and the Kidney – Dr. Andrew Allegretti

• 12:20-12:25 pm: Faculty Q&A – Drs. Anand Vaidya, Andrew Allegretti, and Richard Glassock

• 12:25-1:55 pm: Break

• 1:55-2:25 pm: Pathophysiology of Acute Kidney Injury – Dr. Joseph Bonventre

• 2:25-2:55 pm: Acute Kidney Injury Syndromes – Dr. Alice Sheridan

• 2:55-3:25 pm: ICU Nephrology and Continuous Renal Replacement Therapies – Dr. Andrew Allegretti

• 3:25-3:30 pm: Faculty Q&A – Drs. Joseph Bonventre, Alice Sheridan, and Andrew Allegretti

• 3:30-3:40 pm: Break

• 3:40-4:25 pm: Cancer and Acute Kidney Injury – Dr. Abdullah Jalal

• 4:25-4:55 pm: Paraprotein-Induced Kidney Injury – Dr. Raad Chowdhury

• 4:55-5:25 pm: KEYNOTE: Kidney PAL Program – Dr. Samantha Gelfand

• 5:25-5:55 pm: Pathophysiology and Treatment of Diabetic Kidney Disease – Dr. Gearoid McMahon

• 5:55-6:40 pm: APOL1 and Kidney Disease – Dr. Opeyemi Olabisi

• 6:40-6:50 pm: Faculty Q&A – Drs. Samantha Gelfand, Opeyemi Olabisi, Raad Chowdhury, and Gearoid McMahon

• 6:50 pm: Adjourn Day 4 Live Program

Self-Paced Study (Pre-recorded sessions):

• Interstitial Nephritis – Dr. Julie Paik

• Ethics – Dr. Kathleen McFadden

• Pregnancy and Renal Disease – Dr. Jessica Tangren

Day 5: Friday, August 14, 2026

• 8:45-8:50 am: Day 5 Announcements – Course Directors

• 8:50-9:20 am: Patient Perspective: Dialysis Dosing – Dr. John Kevin Tucker

• 9:20-9:50 am: Hemodiafiltration – Dr. John Kevin Tucker

• 9:50-10:35 am: Mineral and Bone Disease – Dr. David Bushinsky

• 10:35-10:40 am: Faculty Q&A – Drs. David Bushinsky and John Kevin Tucker

• 10:40-10:50 am: Break

• 10:50-11:35 am: Dialysis: A Case-Based Clinical Review and Update – Dr. John Kevin Tucker

• 11:35 am-12:20 pm: Pearls in Mineral and Bone Disease – Dr. David Bushinsky

• 12:20-12:50 pm: Chronic Kidney Disease Epidemiology: A 2026 Update – Dr. Gearoid McMahon

• 12:50-12:55 pm: Faculty Q&A – Drs. Gearoid McMahon, David Bushinsky and John Kevin Tucker

• 12:55-2:25 pm: Break

• 2:25-3:10 pm: Peritoneal Dialysis – Dr. Joanne Bargman

• 3:10-3:55 pm: Peritoneal Dialysis Complications – Dr. Joanne Bargman

• 3:55-4:25 pm: Acute Kidney Injury Related to Immune Checkpoint Inhibitors – Dr. Shruti Gupta

• 4:25-4:30 pm: Faculty Q&A – Drs. Joanne Bargman and Shruti Gupta

• 4:30-4:40 pm: Break

• 4:40-5:10 pm: Mesoamerican Nephropathy – Dr. David Friedman

• 5:10-5:40 pm: Ultrasound for the Clinical Nephrologist – Dr. Adina Voiculescu

• 5:40-6:25 pm: Dialysis Vascular Access: Assessment and Complications – Dr. Dirk Hentschel

• 6:25-6:35 pm: Faculty Q&A – Drs. Adina Voiculescu, Dirk Hentschel, and David Friedman

• 6:35-6:40 pm: Closing Remarks